Berlin Heart GmbH

Medical Technology · Berlin

Berlin Heart GmbH is a medical technology company based in Berlin, Germany. The company operates in the German medical devices market under the EU Medical Device Regulation (MDR 2017/745).

Content in German

The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.

Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.

Berlin Heart GmbH Address & Contact

Address

Wiesenweg 10
12247 Berlin

Berlin Heart GmbH Overview

Berlin Heart GmbH in Berlin is a medical technology company specializing in mechanical circulatory support systems. Founded in 1996, the Berlin-based company has developed the EXCOR ventricular support system, which is used as a heart support system for children and adults with severe heart failure. Berlin Heart is particularly known for its pediatric heart support system, which is the most widely used system of its kind for children worldwide. With over 25 years of experience in medical technology, Berlin Heart specializes in the development and manufacture of high-quality products that significantly improve patients' quality of life.

Services and Products

The core product of Berlin Heart is the EXCOR Pediatric System, a pneumatically operated ventricular support system for children. In addition, the company offers the EXCOR Adult System for adult patients with terminal heart failure, which is used as a bridge to heart transplantation or cardiac recovery. Both systems are designed to be customized to meet patients' needs and provide high comfort. It is also important to mention that Berlin Heart not only develops systems for mechanical support but also provides comprehensive clinical support, training for cardiac surgeons and intensive care staff, as well as a globally available emergency service network.

  • EXCOR Pediatric System: The most widely used ventricular support system worldwide for children with heart failure.
  • EXCOR Adult System: Designed for adult patients to support until transplantation.
  • Clinical Training: Comprehensive training for healthcare professionals for optimal use of the products.
  • Emergency Service: 24/7 support through a global network of specialists.

All products are certified as Class III medical devices under EU-MDR, underscoring the high quality and safety of the products. The strict regulatory requirements that must be met to obtain such certifications demonstrate Berlin Heart's commitment to the safety and efficacy of its products.

Location Berlin

Berlin is the founding and main headquarters of Berlin Heart and offers an excellent environment for research and development as a health and biotech location. The city has established itself as a significant center for innovative medical technology and cardiovascular technologies in Germany. In Berlin, Berlin Heart works closely with renowned clinics such as Charité - Universitätsmedizin Berlin and the German Heart Center Berlin (DHZB), which are not only valuable research partners but also serve as testing grounds for new products. These collaborations promote knowledge exchange and allow Berlin Heart to integrate the latest medical advancements into its products.

Furthermore, the geographical location in Berlin provides Berlin Heart with access to a variety of networks within the European medical technology industry. The company benefits from close collaboration with universities, research institutions, and other medical technology companies that develop innovative approaches and technologies. Through these synergies, Berlin Heart can continuously work on improving its products and the company's innovative capabilities, which directly impacts patient care.

More medical technology companies: Medical Technology Overview | Pharmaceutical Companies | Laboratories

Frequently asked questions about Berlin Heart GmbH

What does Berlin Heart GmbH do?

Berlin Heart GmbH is a company in the medical technology sector based in Berlin. The company develops, manufactures or distributes medical devices, instruments or systems for use in healthcare facilities.

Where is Berlin Heart GmbH based?

Berlin Heart GmbH is based in Berlin. Detailed information can be found on the company website.

In which area of medical technology does Berlin Heart GmbH operate?

Berlin Heart GmbH operates in the medical technology sector and offers solutions for healthcare facilities, hospitals and practices. The exact areas of activity can be found on the company website.

Profile incomplete ☎ Phone 🌐 Website

About Medical Technology

Germany's medical technology sector is one of the most important in the world. With annual revenues of approximately EUR 36 billion and more than 1,400 companies, Germany ranks as the third-largest medical technology market globally (SPECTARIS 2023), after the United States and Japan. The sector encompasses the development, manufacture and distribution of an extraordinarily wide range of products: in-vitro diagnostic (IVD) devices, medical imaging systems (CT, MRI, ultrasound), implants such as hip and knee prostheses, cardiac pacemakers, surgical instruments, hospital beds, wound care products and medical software classified as a Software as a Medical Device (SaMD). In Germany and across the European Union, medical devices must comply with the EU Medical Device Regulation (MDR 2017/745), which replaced the former Medical Devices Directive (MDD 93/42/EEC). Devices are classified into risk classes I, IIa, IIb and III. Higher-risk classes require a conformity assessment by a designated Notified Body (benannte Stelle) before a CE mark can be affixed. The CE mark signals that the product meets EU safety, performance and quality requirements and may be placed on the European market. Key medtech clusters in Germany include the Munich and Nuremberg region in Bavaria, the Rhine-Main area in Hesse, Tuttlingen in Baden-Württemberg (known as the world capital of surgical instruments) and the Hamburg metropolitan area. This directory lists CE-certified manufacturers, distributors and suppliers across the German medtech sector with full contact details.

Germany as a Global Medical Technology Hub

Germany's position as the world's third-largest medical technology market is underpinned by a combination of industrial engineering excellence, a well-funded healthcare system and a highly productive research landscape. The German medtech sector is characterised by a large number of small and medium-sized enterprises (SMEs) that are often hidden champions (Weltmarktführer) in specialised niches. Unlike the pharmaceutical sector, where large corporations dominate, the medtech industry is more fragmented and innovative, with frequent spin-offs from university hospitals and engineering faculties. Key product categories include imaging systems (MRI, CT, X-ray, ultrasound), endoscopy and minimally invasive surgical tools, orthopaedic implants, cardiovascular devices, in-vitro diagnostics, dental equipment, ophthalmic devices, wound care systems and hospital IT and medical software. Germany is particularly renowned for its surgical instrument manufacturing, centred in Tuttlingen, Baden-Württemberg, which supplies operating theatres worldwide. The annual Medica trade fair in Düsseldorf is the world's largest medical technology exhibition and serves as a global industry showcase.

EU MDR Compliance and CE Marking for German Manufacturers

The EU Medical Device Regulation (MDR 2017/745) replaced the former Medical Devices Directive (MDD 93/42/EEC) and has applied in full since May 2021, with transition periods for legacy devices extended to 2028 in some cases. For German manufacturers selling in the EU market, MDR compliance is a legal necessity. The regulation introduced significantly strengthened requirements compared to the old MDD: more rigorous clinical evidence requirements, mandatory post-market clinical follow-up (PMCF), unique device identification (UDI) registration in the EUDAMED database, increased obligations for Notified Bodies, and stricter rules for software as a medical device (SaMD). The risk classification system under MDR uses four classes (I, IIa, IIb, III) based on the intended purpose, duration of use and body contact of the device. Manufacturers must appoint an authorised representative in the EU if they are not themselves based in an EU member state, and they must maintain a quality management system. In Germany, the Bundesnetzagentur and state authorities support MDR enforcement alongside BfArM.

Innovation and Research in German Medtech

Germany's medtech innovation ecosystem benefits from close collaboration between industry, university hospitals (Universitätsklinika), applied research institutes (such as those of the Fraunhofer and Helmholtz networks) and health technology assessment bodies. The Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) and the Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) play important roles in assessing which new medical technologies are eligible for reimbursement by statutory health insurance (GKV). This reimbursement pathway, known as the NUB process (Neue Untersuchungs- und Behandlungsmethoden) for hospital technologies, is a key milestone for commercial success in Germany. Innovative devices that receive a positive NUB assessment can be reimbursed at negotiated rates by statutory insurers, providing a significant market access advantage.

Innovation Fields and Future Technologies

The German medical technology sector is driving numerous future fields forward. AI-supported diagnostics and image analysis are revolutionising radiology and pathology; algorithms for the early detection of cancer and cardiovascular disease are increasingly receiving CE approvals as Software as a Medical Device (SaMD). Robot-assisted surgical systems, led by products from Siemens Healthineers, Brainlab and Karl Storz, are improving precision in complex procedures. Minimally invasive technologies, implantable pacemakers and intelligent prostheses with sensory feedback demonstrate the breadth of innovation. Point-of-care diagnostics enables rapid tests directly in the doctor's surgery or at the bedside. Telemedicine and digital patient records promote networking between medical devices and clinical workflows. The Federal Ministry of Education and Research (BMBF) funding programme specifically supports the development of innovative medical technology products through cooperation between industry and universities.

What does the medical technology sector cover?

Medical technology encompasses the development, manufacture and distribution of medical devices, instruments, software and accessories used to diagnose, prevent, monitor or treat diseases. Germany ranks among the world's leading medical technology hubs.

How are medical devices approved in Germany?

Medical devices in Germany and the EU must comply with the EU Medical Device Regulation (MDR 2017/745) and carry the CE mark. Depending on the risk class, conformity assessments by notified bodies are required.

Where can I find medical technology companies in Germany?

Medical technology companies in Germany can be found through industry associations such as SPECTARIS, BVMed or ZVEI, and via the EUDAMED EU database for registered manufacturers. Sanoliste provides a searchable directory of manufacturers, distributors and suppliers across the German medical technology sector.

How many medical technology companies are there in Germany?

Germany has more than 1,400 medical technology companies generating annual revenues of approximately EUR 36 billion (SPECTARIS 2023), making it the third-largest medical technology market in the world. The majority of companies are small and medium-sized enterprises (SMEs), many of which are world market leaders in their niche.

What are the risk classes for medical devices under the EU MDR?

The EU Medical Device Regulation (MDR 2017/745) classifies medical devices into four risk classes: Class I (lowest risk, e.g. bandages, glasses frames), Class IIa (medium risk, e.g. hearing aids, contact lenses), Class IIb (higher medium risk, e.g. infusion pumps, ventilators) and Class III (highest risk, e.g. implantable cardiac devices, neurosurgical instruments). Higher classes require more rigorous conformity assessment by a Notified Body.

Where are the main medical technology clusters in Germany?

Germany's medical technology industry is concentrated in several regional clusters. Bavaria (particularly Munich and Nuremberg) and Baden-Württemberg (notably Tuttlingen, globally known for surgical instruments) are the two strongest regions. Other significant clusters include the Rhine-Main area in Hesse, the Hamburg metropolitan region, the Ruhr area in North Rhine-Westphalia and the Berlin-Brandenburg region.

What is a Notified Body (benannte Stelle) and why does it matter?

A Notified Body (benannte Stelle) is an independent third-party organisation designated by an EU member state to assess whether medical devices meet the requirements of the MDR before they can carry the CE mark. For Class IIa, IIb and III devices, manufacturers must have their quality management system and technical documentation assessed by a Notified Body. In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) oversees market surveillance, while several German organisations hold Notified Body status under the MDR.

Last updated: 17.04.2026 · Category: Medical Technology